Preventing Urinary Tract Infections | NYU Langone Health
NYU Langone doctors recommend lifestyle changes to help prevent urinary tract infections.
Preventing Urinary Tract Infections in Children | NYU Langone Health
Doctors at Hassenfeld Children’s Hospital at NYU Langone recommend improved toileting habits to prevent urinary tract infections in children.
Preventing Vaginal Cancer | NYU Langone Health
NYU Langone doctors recommend HPV vaccination and other measures to prevent vaginal cancer.
Preventive Treatment for People at High Risk for Colorectal Cancer | NYU Langone Health
Experts at NYU Langone’s Perlmutter Cancer Center can make recommendations to help prevent colorectal cancer in people at high risk.
Preventive Treatments for Breast Cancer | NYU Langone Health
Doctors at NYU Langone’s Perlmutter Cancer Center may recommend treatments to reduce the risk of developing breast cancer in women at high risk.
Primary Care Services | NYU Langone Health
NYU Langone physicians offer primary care and internal medicine services close to where you live and work.
Primary Care Services Doctors | NYU Langone Health
Find a doctor at the Primary Care Services at NYU Langone.
Primary Central Nervous System Lymphoma | NYU Langone Health
Perlmutter Cancer Center specialists collaborate to manage primary central nervous system lymphoma, an immune system cancer.
Primary Ciliary Dyskinesia Foundation (PCDF) Clinical Registry
Primary ciliary dyskinesia (PCD) is a disease that results in chronic cough and recurrent respiratory and sinus infections, among other symptoms. PCD is caused by dysfunction of cilia, which are tiny hair-like structures that line the sinus and respiratory tract, as well as other parts of the body. Our purpose for this research study is to learn more about PCD through the creation of a secure electronic clinical registry. Through this registry, The researchers will be able to follow people living with PCD over time to learn more about how PCD affects people’s health and the treatment people take.
Proactive infliximab optimization using a pharmacokinetic dashboard versus standard of care in patients with Crohn s disease: The OPTIMIZE Trial
The purpose of this study is to find out if using a computer program (called iDose) to guide infliximab dosing is more effective and safer than using standard infliximab dosing over 52 weeks. All patients in this study will be receiving infliximab as part of their medical care, this study is only looking at two different methods of determining the dose and timing of administration. iDose is a computer program that uses personalized information entered by an iDose Operator (person who is not involved in your clinical care) including previous infliximab doses, your current blood levels of infliximab, and other lab values such as albumin to predict the amount of infliximab that will be used by your body in the future. This information can help your gastroenterologist recommend a personalized schedule of dosing to maintain the target level of infliximab in your body. This is different from standard dosing where the dose and schedule is the same for everyone, and would only be altered later if the drug first doesn’t work or stops working for you.